Pfizer PFE stock has risen 7.3% in the past three months compared with an increase of 2.9% for the industry. The stock has ...

The FDA issued draft guidance on oncology clinical trials, taking the first steps toward formalizing a position that it's ...

In August, the FDA also approved updated mRNA COVID-19 vaccines, which also have a "monovalent (single) component" ...

These extra doses will bring more highly specialised work making these novel molecules to contract manufacturing ...

KP.2-adapted COVID-19 vaccine received FDA approval. Manufacturing Optimization Program aims to deliver $1.5b in savings by ...

Pfizer will begin shipping its new shot immediately ... "We appreciate the U.S. FDA's timely review and encourage individuals to speak to their healthcare providers about receiving their updated ...

Pharma giant Pfizer said that a drug aimed at helping cancer patients losing appetite and muscle mass showed positive results ...

On August 22, Moderna announced that FDA approved its supplemental Biologics License Application ... we saw more than 600,000 hospitalizations due to COVID in the U.S.” On the same day, Pfizer and ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Pfizer and Moderna's updated COVID-19 vaccines amid a summer wave of "very high" coronavirus levels in wastewater, according to the ...

Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.

Pfizer's recent financial performance shows 14% YoY operational growth excluding COVID sales. Check out more on PFE stock ...

CNW/ - Today, Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory Syncytial Virus (RSV) in older adults in Canada for 2024-2025 ...